Application
CCNG1 Antibody (N-term) western blot analysis in Hela cell line lysates (35ug/lane).This demonstrates the CCNG1 antibody detected the CCNG1 protein (arrow).Application
CCNG1 Antibody (N-term) flow cytometric analysis of Hela cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Product Name | CCNG1 Antibody (N-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBFC |
| WB:1:100~500 FC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | CCNG, CYCG1 |
|---|---|
| Alternative Names | CCNG1 CCNG CYCG1 Cyclin-G1 |
| Molecular Weight(MW) | 34074 Da |
| Function | May play a role in growth regulation. Is associated with G2/M phase arrest in response to DNA damage. May be an intermediate by which p53 mediates its role as an inhibitor of cellular proliferation (By similarity) |
| Tissue Specificity | High levels in skeletal muscle, ovary, kidney and colon |
| Cellular Localization | Nucleus. Note=DNA replication foci after DNA damage |
| Entrez Gene | 900 |
|---|---|
| Nucleotide Accession | NP_004051.1 NP_954854.1 |
Application
CCNG1 Antibody (N-term) western blot analysis in Hela cell line lysates (35ug/lane).This demonstrates the CCNG1 antibody detected the CCNG1 protein (arrow).
Application
CCNG1 Antibody (N-term) flow cytometric analysis of Hela cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Application Notes | WB:1:100~500 FC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
